AU4416189A - Therapeutic and diagnostic methods using soluble t cell surface molecules - Google Patents
Therapeutic and diagnostic methods using soluble t cell surface moleculesInfo
- Publication number
- AU4416189A AU4416189A AU44161/89A AU4416189A AU4416189A AU 4416189 A AU4416189 A AU 4416189A AU 44161/89 A AU44161/89 A AU 44161/89A AU 4416189 A AU4416189 A AU 4416189A AU 4416189 A AU4416189 A AU 4416189A
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic
- soluble
- cell surface
- diagnostic methods
- surface molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2815—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- AIDS & HIV (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Rehabilitation Therapy (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25455188A | 1988-10-06 | 1988-10-06 | |
US254551 | 1988-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4416189A true AU4416189A (en) | 1990-05-01 |
Family
ID=22964717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44161/89A Abandoned AU4416189A (en) | 1988-10-06 | 1989-10-05 | Therapeutic and diagnostic methods using soluble t cell surface molecules |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR900702370A (en) |
AU (1) | AU4416189A (en) |
CA (1) | CA2000308A1 (en) |
WO (1) | WO1990004180A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU643195B2 (en) * | 1988-12-15 | 1993-11-11 | Astra Aktiebolag | Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
AU651346B2 (en) * | 1989-11-15 | 1994-07-21 | National Jewish Center For Immunology And Respiratory Medicine | Method for measuring T-cell surface antigens in humans |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5426029A (en) * | 1986-03-31 | 1995-06-20 | T Cell Diagnostics, Inc. | Therapeutic and diagnostic methods using leukocyte surface antigens |
US5527884A (en) * | 1993-12-21 | 1996-06-18 | President And Fellows Of Harvard College | Mediators of chronic allograft rejection and DNA molecules encoding them |
US5658745A (en) * | 1995-02-17 | 1997-08-19 | E. I. Du Pont De Nemours And Company | Cell enumeration immunoassay |
US7259247B1 (en) | 1997-09-23 | 2007-08-21 | Bundersrespublik Deutschaland Letztvertreten Durch Den Direktor Des Robert-Koch-Institutes | Anti-human T-cell costimulating polypeptide monoclonal antibodies |
DE19821060A1 (en) | 1997-09-23 | 1999-04-15 | Bundesrepublik Deutschland Let | T cell co-stimulating polypeptide, monoclonal antibodies, and the production and use thereof |
JPH11271304A (en) * | 1998-03-24 | 1999-10-08 | Jcr Pharmaceuticals Co Ltd | Hiv infection diagnosing method |
CA2562764A1 (en) | 2004-04-23 | 2005-11-03 | Richard Kroczek | Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo |
AU2014230447A1 (en) * | 2013-03-15 | 2015-09-17 | Westfaelische Wilhelms-Universitaet Muenster | Detection of acute renal allograft rejection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4707443A (en) * | 1985-04-19 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same |
DE3628718A1 (en) * | 1985-12-03 | 1987-06-04 | Bayer Ag | RELEASED INTERLEUKIN-2 RECEPTORS AS AN INDICATOR FOR IMMUNE REACTIONS AND NEOPLASIA |
US5006459A (en) * | 1986-03-31 | 1991-04-09 | T Cell Sciences, Inc. | Therapeutic and diagnostic methods using soluble T cell surface molecules |
-
1989
- 1989-10-05 KR KR1019900701202A patent/KR900702370A/en not_active Application Discontinuation
- 1989-10-05 AU AU44161/89A patent/AU4416189A/en not_active Abandoned
- 1989-10-05 WO PCT/US1989/004413 patent/WO1990004180A1/en unknown
- 1989-10-06 CA CA002000308A patent/CA2000308A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU643195B2 (en) * | 1988-12-15 | 1993-11-11 | Astra Aktiebolag | Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
AU651346B2 (en) * | 1989-11-15 | 1994-07-21 | National Jewish Center For Immunology And Respiratory Medicine | Method for measuring T-cell surface antigens in humans |
Also Published As
Publication number | Publication date |
---|---|
CA2000308A1 (en) | 1990-04-06 |
WO1990004180A1 (en) | 1990-04-19 |
KR900702370A (en) | 1990-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0261174A4 (en) | Therapeutic and diagnostic methods using soluble t cell surface molecules | |
AU7813191A (en) | Novel immunoconjugates and methods for their use in tumor therapy | |
AU589438B2 (en) | Transplantable artificial tissue and process | |
AU4472793A (en) | Methods for diagnosis and therapy using defined regions of the T cell antigen receptor | |
AU4175189A (en) | Improvements in or relating to humidifying apparatus | |
AU2899089A (en) | Methods for part-of-speech determination and usage | |
AU599400B2 (en) | Titanocenes and their use | |
AU6399786A (en) | Polypeptides used in the diagnosis and therapy of AIDS | |
EP0328027A3 (en) | Novel soluble polyimidesiloxanes and methods for their preparation and use | |
AU4225889A (en) | Peptide synthesis method and solid support for use in the method | |
AU4053689A (en) | Compositions and in situ methods for forming films on body tissue | |
AU6785987A (en) | Selecting and testing antibodies for cancer therapy | |
AU5049890A (en) | Methods and apparatus using galvanic immunoelectrodes | |
AU4647089A (en) | Electro-therapy apparatus and method | |
AU3375789A (en) | Determination of glucose in whole blood | |
AU3652889A (en) | Compounds for use in medicine | |
AU1907788A (en) | N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy | |
AU6867787A (en) | Process and kit for drug detection | |
AU4416189A (en) | Therapeutic and diagnostic methods using soluble t cell surface molecules | |
AU7752587A (en) | Ultrasound therapy device | |
AU2616788A (en) | Device for use in the treatment of lymphocytes | |
AU6835387A (en) | Device and instrument for receiving and introducing tissues in the human body | |
AU7838387A (en) | Docking head and plate | |
AU4494289A (en) | Improvements in and relating to catheters | |
AU3062089A (en) | Apparatus for use in the manufacture of batteries |